Oxidized LDL induces vimentin secretion by macrophages and contributes to atherosclerotic inflammation

Activated macrophages show increased expression of vimentin, an intermediate filament protein. Macrophages secrete vimentin into extracellular space; however, the functions of extracellular vimentin and the process of vimentin secretion are not clearly defined. We found that oxidized low-density lip...

Full description

Saved in:
Bibliographic Details
Published inJournal of molecular medicine (Berlin, Germany) Vol. 98; no. 7; pp. 973 - 983
Main Authors Kim, SeoYeon, Cho, Wonkyoung, Kim, Inyeong, Lee, Sang-Hak, Oh, Goo Taeg, Park, Young Mi
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.07.2020
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Activated macrophages show increased expression of vimentin, an intermediate filament protein. Macrophages secrete vimentin into extracellular space; however, the functions of extracellular vimentin and the process of vimentin secretion are not clearly defined. We found that oxidized low-density lipoproteins (oxLDL) via CD36 induced vimentin secretion in macrophages. We also revealed that extracellular vimentin induced macrophages to release inflammatory cytokines and augmented oxLDL-induced release of TNF-α and IL-6. Extracellular vimentin activated NF-κB signaling via phosphorylation of focal adhesion kinase (p-FAK) and IκB kinase (p-IκK). Extracellular vimentin also amplified the oxLDL-induced p-IκK increase and IκB decrease. Vimentin-induced TNF-α release was not dependent on Dectin-1, which is known to bind vimentin. We measured serum vimentin concentrations and found that patients with atherosclerotic coronary artery disease had higher levels of serum vimentin than normal subjects. Circulating oxLDL and vimentin concentrations showed a high degree of correlation. In mouse experiments, vimentin concentration was higher in the sera of apoE null mice with western diet–induced atherosclerosis than in the sera of chow diet–fed apoE null mice without atherosclerosis. We concluded that vimentin is secreted by oxLDL/CD36 interaction in macrophages and extracellular vimentin promotes macrophage release of pro-inflammatory cytokines. This may contribute to atherosclerotic inflammation and based on our analysis of serum vimentin, we suggest serum vimentin as a predictive marker for atherosclerosis. Key messages OxLDL via CD36 induces secretion of vimentin, a cytoskeletal protein in macrophages. Extracellular vimentin induces macrophages to release proinflammatory cytokines such as tumor necrotizing factor-alpha (TNF-α) and this process is mediated by activation of focal adhesion kinase (FAK) and NF-ƙB signaling. Serum concentrations of vimentin in coronary artery disease patients are higher than that in control group. Vimentin concentration is strongly correlated with oxLDL concentration in serum.
AbstractList Activated macrophages show increased expression of vimentin, an intermediate filament protein. Macrophages secrete vimentin into extracellular space; however, the functions of extracellular vimentin and the process of vimentin secretion are not clearly defined. We found that oxidized low-density lipoproteins (oxLDL) via CD36 induced vimentin secretion in macrophages. We also revealed that extracellular vimentin induced macrophages to release inflammatory cytokines and augmented oxLDL-induced release of TNF-α and IL-6. Extracellular vimentin activated NF-κB signaling via phosphorylation of focal adhesion kinase (p-FAK) and IκB kinase (p-IκK). Extracellular vimentin also amplified the oxLDL-induced p-IκK increase and IκB decrease. Vimentin-induced TNF-α release was not dependent on Dectin-1, which is known to bind vimentin. We measured serum vimentin concentrations and found that patients with atherosclerotic coronary artery disease had higher levels of serum vimentin than normal subjects. Circulating oxLDL and vimentin concentrations showed a high degree of correlation. In mouse experiments, vimentin concentration was higher in the sera of apoE null mice with western diet–induced atherosclerosis than in the sera of chow diet–fed apoE null mice without atherosclerosis. We concluded that vimentin is secreted by oxLDL/CD36 interaction in macrophages and extracellular vimentin promotes macrophage release of pro-inflammatory cytokines. This may contribute to atherosclerotic inflammation and based on our analysis of serum vimentin, we suggest serum vimentin as a predictive marker for atherosclerosis. Key messages OxLDL via CD36 induces secretion of vimentin, a cytoskeletal protein in macrophages. Extracellular vimentin induces macrophages to release proinflammatory cytokines such as tumor necrotizing factor-alpha (TNF-α) and this process is mediated by activation of focal adhesion kinase (FAK) and NF-ƙB signaling. Serum concentrations of vimentin in coronary artery disease patients are higher than that in control group. Vimentin concentration is strongly correlated with oxLDL concentration in serum.
Activated macrophages show increased expression of vimentin, an intermediate filament protein. Macrophages secrete vimentin into extracellular space; however, the functions of extracellular vimentin and the process of vimentin secretion are not clearly defined. We found that oxidized low-density lipoproteins (oxLDL) via CD36 induced vimentin secretion in macrophages. We also revealed that extracellular vimentin induced macrophages to release inflammatory cytokines and augmented oxLDL-induced release of TNF-α and IL-6. Extracellular vimentin activated NF-κB signaling via phosphorylation of focal adhesion kinase (p-FAK) and IκB kinase (p-IκK). Extracellular vimentin also amplified the oxLDL-induced p-IκK increase and IκB decrease. Vimentin-induced TNF-α release was not dependent on Dectin-1, which is known to bind vimentin. We measured serum vimentin concentrations and found that patients with atherosclerotic coronary artery disease had higher levels of serum vimentin than normal subjects. Circulating oxLDL and vimentin concentrations showed a high degree of correlation. In mouse experiments, vimentin concentration was higher in the sera of apoE null mice with western diet-induced atherosclerosis than in the sera of chow diet-fed apoE null mice without atherosclerosis. We concluded that vimentin is secreted by oxLDL/CD36 interaction in macrophages and extracellular vimentin promotes macrophage release of pro-inflammatory cytokines. This may contribute to atherosclerotic inflammation and based on our analysis of serum vimentin, we suggest serum vimentin as a predictive marker for atherosclerosis. KEY MESSAGES: OxLDL via CD36 induces secretion of vimentin, a cytoskeletal protein in macrophages. Extracellular vimentin induces macrophages to release proinflammatory cytokines such as tumor necrotizing factor-alpha (TNF-α) and this process is mediated by activation of focal adhesion kinase (FAK) and NF-ƙB signaling. Serum concentrations of vimentin in coronary artery disease patients are higher than that in control group. Vimentin concentration is strongly correlated with oxLDL concentration in serum.Activated macrophages show increased expression of vimentin, an intermediate filament protein. Macrophages secrete vimentin into extracellular space; however, the functions of extracellular vimentin and the process of vimentin secretion are not clearly defined. We found that oxidized low-density lipoproteins (oxLDL) via CD36 induced vimentin secretion in macrophages. We also revealed that extracellular vimentin induced macrophages to release inflammatory cytokines and augmented oxLDL-induced release of TNF-α and IL-6. Extracellular vimentin activated NF-κB signaling via phosphorylation of focal adhesion kinase (p-FAK) and IκB kinase (p-IκK). Extracellular vimentin also amplified the oxLDL-induced p-IκK increase and IκB decrease. Vimentin-induced TNF-α release was not dependent on Dectin-1, which is known to bind vimentin. We measured serum vimentin concentrations and found that patients with atherosclerotic coronary artery disease had higher levels of serum vimentin than normal subjects. Circulating oxLDL and vimentin concentrations showed a high degree of correlation. In mouse experiments, vimentin concentration was higher in the sera of apoE null mice with western diet-induced atherosclerosis than in the sera of chow diet-fed apoE null mice without atherosclerosis. We concluded that vimentin is secreted by oxLDL/CD36 interaction in macrophages and extracellular vimentin promotes macrophage release of pro-inflammatory cytokines. This may contribute to atherosclerotic inflammation and based on our analysis of serum vimentin, we suggest serum vimentin as a predictive marker for atherosclerosis. KEY MESSAGES: OxLDL via CD36 induces secretion of vimentin, a cytoskeletal protein in macrophages. Extracellular vimentin induces macrophages to release proinflammatory cytokines such as tumor necrotizing factor-alpha (TNF-α) and this process is mediated by activation of focal adhesion kinase (FAK) and NF-ƙB signaling. Serum concentrations of vimentin in coronary artery disease patients are higher than that in control group. Vimentin concentration is strongly correlated with oxLDL concentration in serum.
Activated macrophages show increased expression of vimentin, an intermediate filament protein. Macrophages secrete vimentin into extracellular space; however, the functions of extracellular vimentin and the process of vimentin secretion are not clearly defined. We found that oxidized low-density lipoproteins (oxLDL) via CD36 induced vimentin secretion in macrophages. We also revealed that extracellular vimentin induced macrophages to release inflammatory cytokines and augmented oxLDL-induced release of TNF-α and IL-6. Extracellular vimentin activated NF-κB signaling via phosphorylation of focal adhesion kinase (p-FAK) and IκB kinase (p-IκK). Extracellular vimentin also amplified the oxLDL-induced p-IκK increase and IκB decrease. Vimentin-induced TNF-α release was not dependent on Dectin-1, which is known to bind vimentin. We measured serum vimentin concentrations and found that patients with atherosclerotic coronary artery disease had higher levels of serum vimentin than normal subjects. Circulating oxLDL and vimentin concentrations showed a high degree of correlation. In mouse experiments, vimentin concentration was higher in the sera of apoE null mice with western diet–induced atherosclerosis than in the sera of chow diet–fed apoE null mice without atherosclerosis. We concluded that vimentin is secreted by oxLDL/CD36 interaction in macrophages and extracellular vimentin promotes macrophage release of pro-inflammatory cytokines. This may contribute to atherosclerotic inflammation and based on our analysis of serum vimentin, we suggest serum vimentin as a predictive marker for atherosclerosis.Key messagesOxLDL via CD36 induces secretion of vimentin, a cytoskeletal protein in macrophages.Extracellular vimentin induces macrophages to release proinflammatory cytokines such as tumor necrotizing factor-alpha (TNF-α) and this process is mediated by activation of focal adhesion kinase (FAK) and NF-ƙB signaling.Serum concentrations of vimentin in coronary artery disease patients are higher than that in control group.Vimentin concentration is strongly correlated with oxLDL concentration in serum.
Activated macrophages show increased expression of vimentin, an intermediate filament protein. Macrophages secrete vimentin into extracellular space; however, the functions of extracellular vimentin and the process of vimentin secretion are not clearly defined. We found that oxidized low-density lipoproteins (oxLDL) via CD36 induced vimentin secretion in macrophages. We also revealed that extracellular vimentin induced macrophages to release inflammatory cytokines and augmented oxLDL-induced release of TNF-α and IL-6. Extracellular vimentin activated NF-κB signaling via phosphorylation of focal adhesion kinase (p-FAK) and IκB kinase (p-IκK). Extracellular vimentin also amplified the oxLDL-induced p-IκK increase and IκB decrease. Vimentin-induced TNF-α release was not dependent on Dectin-1, which is known to bind vimentin. We measured serum vimentin concentrations and found that patients with atherosclerotic coronary artery disease had higher levels of serum vimentin than normal subjects. Circulating oxLDL and vimentin concentrations showed a high degree of correlation. In mouse experiments, vimentin concentration was higher in the sera of apoE null mice with western diet-induced atherosclerosis than in the sera of chow diet-fed apoE null mice without atherosclerosis. We concluded that vimentin is secreted by oxLDL/CD36 interaction in macrophages and extracellular vimentin promotes macrophage release of pro-inflammatory cytokines. This may contribute to atherosclerotic inflammation and based on our analysis of serum vimentin, we suggest serum vimentin as a predictive marker for atherosclerosis. KEY MESSAGES: OxLDL via CD36 induces secretion of vimentin, a cytoskeletal protein in macrophages. Extracellular vimentin induces macrophages to release proinflammatory cytokines such as tumor necrotizing factor-alpha (TNF-α) and this process is mediated by activation of focal adhesion kinase (FAK) and NF-ƙB signaling. Serum concentrations of vimentin in coronary artery disease patients are higher than that in control group. Vimentin concentration is strongly correlated with oxLDL concentration in serum.
Author Cho, Wonkyoung
Lee, Sang-Hak
Oh, Goo Taeg
Park, Young Mi
Kim, SeoYeon
Kim, Inyeong
Author_xml – sequence: 1
  givenname: SeoYeon
  surname: Kim
  fullname: Kim, SeoYeon
  organization: Department of Molecular Medicine, College of Medicine, Ewha Womans University
– sequence: 2
  givenname: Wonkyoung
  surname: Cho
  fullname: Cho, Wonkyoung
  organization: Department of Molecular Medicine, College of Medicine, Ewha Womans University
– sequence: 3
  givenname: Inyeong
  surname: Kim
  fullname: Kim, Inyeong
  organization: Department of Molecular Medicine, College of Medicine, Ewha Womans University
– sequence: 4
  givenname: Sang-Hak
  surname: Lee
  fullname: Lee, Sang-Hak
  organization: Division of Cardiology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine
– sequence: 5
  givenname: Goo Taeg
  surname: Oh
  fullname: Oh, Goo Taeg
  organization: Immune and Vascular Cell Network Research Center, National Creative Initiatives, Department of Life Sciences, Ewha Womans University
– sequence: 6
  givenname: Young Mi
  orcidid: 0000-0001-6558-7410
  surname: Park
  fullname: Park, Young Mi
  email: parkym@ewha.ac.kr
  organization: Department of Molecular Medicine, College of Medicine, Ewha Womans University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32451671$$D View this record in MEDLINE/PubMed
BookMark eNp9kU1P3DAQhq0KVBbaP9BDFamXXlLGH7HXRwT9klbiAmfLcSZglNiL7RTor69haStx4GLL0vOMZ-Y9JHshBiTkA4UvFEAdZwAKugUGLVDNeHv3hqyo4KylQsAeWYEWsmWKygNymPNNxVWnxVtywJnoqFR0Rcbzez_43zg0m7NN48OwOMzNLz9jKD40GV3C4mNo-odmti7F7bW9qoQNQ-NiKMn3S6nvEhtbrjHF7KZ6Fu9qsXGy82wf9Xdkf7RTxvfP9xG5_Pb14vRHuzn__vP0ZNM6QXVpFeudw7VSgnGNoAZggik51jGpok4JpJ121PJRyY4qKfueDU52wAZAve75Efm8q7tN8XbBXMzss8NpsgHjkg0TIHXH-JpX9NML9CYuKdTuKsUoE4KBrNTHZ2rpZxzMNvnZpgfzd4MVYDug7ibnhOM_hIJ5jMnsYjI1JvMUk7mr0vqF5Hx5WlRJ1k-vq3yn5vpPuML0v-1XrD9jJabS
CitedBy_id crossref_primary_10_1007_s13402_023_00844_3
crossref_primary_10_1016_j_isci_2023_107145
crossref_primary_10_1186_s12964_025_02062_w
crossref_primary_10_4093_dmj_2022_0332
crossref_primary_10_1016_j_phymed_2022_154305
crossref_primary_10_1007_s00109_021_02109_8
crossref_primary_10_1016_j_chemphyslip_2023_105362
crossref_primary_10_3390_biomedicines10040828
crossref_primary_10_12677_ACM_2023_1392064
crossref_primary_10_1016_j_ijcard_2021_07_010
crossref_primary_10_1186_s12967_022_03562_w
crossref_primary_10_3389_fcvm_2022_879726
crossref_primary_10_1111_imcb_12721
crossref_primary_10_1161_STROKEAHA_120_032111
crossref_primary_10_31857_S0320972524040113
crossref_primary_10_1096_fj_202402322R
crossref_primary_10_1089_dna_2021_0623
crossref_primary_10_1161_JAHA_122_027862
crossref_primary_10_3389_fimmu_2022_837180
crossref_primary_10_1016_j_ceb_2025_102483
crossref_primary_10_1016_j_ceb_2023_102265
crossref_primary_10_1016_j_ceb_2023_102246
crossref_primary_10_3389_fcell_2022_891281
crossref_primary_10_1007_s11883_020_00870_8
crossref_primary_10_3390_v14081814
crossref_primary_10_1134_S0006297924040114
crossref_primary_10_3390_ijms21134675
crossref_primary_10_3390_v13122471
crossref_primary_10_1038_s41419_024_07166_8
crossref_primary_10_1016_j_bbcan_2023_188985
crossref_primary_10_1002_bies_202000078
crossref_primary_10_3390_ijms22147469
crossref_primary_10_1016_j_jbc_2023_104963
Cites_doi 10.1007/s11886-008-0078-1
10.1016/j.cardiores.2005.09.009
10.1038/nature04768
10.1161/01.ATV.20.8.1953
10.1038/ncb898
10.1096/fj.09-151639
10.1093/eurheartj/ehv759
10.2174/1568010054022024
10.1161/01.ATV.16.12.1573
10.1016/j.virol.2013.06.009
10.1134/S0006297908130063
10.1016/B978-1-4831-9942-9.50008-5
10.1016/j.atherosclerosis.2015.02.005
10.1161/01.ATV.20.10.2243
10.1038/s41598-018-34659-2
10.1016/j.cytogfr.2015.04.003
10.1161/CIRCULATIONAHA.104.529297
10.1242/jcs.182097
10.1186/1471-2172-14-6
10.1038/srep35234
10.1016/j.ijcard.2019.02.032
10.1091/mbc.e04-03-0272
10.1093/cvr/cvt117
10.1161/01.ATV.21.5.844
10.1038/nature01323
10.1016/S0021-9258(19)50272-1
10.1242/jcs.111.13.1897
10.2147/ijicmr.S64894
10.12688/f1000research.15967.1
ContentType Journal Article
Copyright Springer-Verlag GmbH Germany, part of Springer Nature 2020
Springer-Verlag GmbH Germany, part of Springer Nature 2020.
Copyright_xml – notice: Springer-Verlag GmbH Germany, part of Springer Nature 2020
– notice: Springer-Verlag GmbH Germany, part of Springer Nature 2020.
DBID AAYXX
CITATION
NPM
3V.
7TK
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOI 10.1007/s00109-020-01923-w
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Neurosciences Abstracts
ProQuest Health & Medical Collection (NC LIVE)
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
ProQuest One Academic Middle East (New)
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1432-1440
EndPage 983
ExternalDocumentID 32451671
10_1007_s00109_020_01923_w
Genre Journal Article
GrantInformation_xml – fundername: National Research Foundation of Korea
  grantid: NRF-2015M3A9B6029133
GroupedDBID ---
-4W
-56
-5G
-BR
-EM
-Y2
-~C
.55
.86
.VR
06C
06D
0R~
0VY
199
1N0
2.D
203
28-
29L
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
36B
3O-
3SX
3V.
4.4
406
408
409
40D
40E
53G
5GY
5QI
5RE
5VS
67N
67Z
6NX
78A
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABJNI
ABJOX
ABKCH
ABKTR
ABLJU
ABMNI
ABMQK
ABNWP
ABOCM
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHXU
ACIWK
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACZOJ
ADBBV
ADHIR
ADIMF
ADINQ
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYPR
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFEXP
AFGCZ
AFKRA
AFLOW
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AOCGG
ARMRJ
ASPBG
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
EBD
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
EN4
EPAXT
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAS
LLZTM
M1P
M4Y
MA-
N2Q
N9A
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
P19
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R89
R9I
RHV
RIG
RNI
RNS
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S3A
S3B
SAP
SBL
SBY
SCLPG
SDH
SDM
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZN
T13
T16
TSG
TSK
TSV
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK6
WK8
X7M
YLTOR
Z45
Z7R
Z7U
Z7W
Z7Z
Z82
Z83
Z87
Z8M
Z8O
Z8Q
Z8T
Z8V
Z8W
Z91
ZMTXR
ZOVNA
~EX
AAPKM
AAYXX
ABBRH
ABDBE
ADHKG
AFDZB
AFOHR
AGQPQ
AHPBZ
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
NPM
7TK
7XB
8FK
ABRTQ
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
ID FETCH-LOGICAL-c419t-72bcce8774239e07d024276f109171c74e159c1a3f7651766bb2dc6502d0e98b3
IEDL.DBID 7X7
ISSN 0946-2716
1432-1440
IngestDate Thu Jul 10 17:43:03 EDT 2025
Sat Aug 23 14:30:29 EDT 2025
Wed Feb 19 02:29:49 EST 2025
Tue Jul 01 02:55:38 EDT 2025
Thu Apr 24 23:08:39 EDT 2025
Fri Feb 21 02:25:55 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords Vimentin
NF-κB signaling
TNF-α
Intermediate filament
Oxidized LDL
Atherosclerosis
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c419t-72bcce8774239e07d024276f109171c74e159c1a3f7651766bb2dc6502d0e98b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-6558-7410
OpenAccessLink https://ir.ymlib.yonsei.ac.kr/handle/22282913/183875
PMID 32451671
PQID 2421244206
PQPubID 48876
PageCount 11
ParticipantIDs proquest_miscellaneous_2406952383
proquest_journals_2421244206
pubmed_primary_32451671
crossref_primary_10_1007_s00109_020_01923_w
crossref_citationtrail_10_1007_s00109_020_01923_w
springer_journals_10_1007_s00109_020_01923_w
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-07-01
PublicationDateYYYYMMDD 2020-07-01
PublicationDate_xml – month: 07
  year: 2020
  text: 2020-07-01
  day: 01
PublicationDecade 2020
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Germany
– name: New York
PublicationTitle Journal of molecular medicine (Berlin, Germany)
PublicationTitleAbbrev J Mol Med
PublicationTitleAlternate J Mol Med (Berl)
PublicationYear 2020
Publisher Springer Berlin Heidelberg
Springer Nature B.V
Publisher_xml – name: Springer Berlin Heidelberg
– name: Springer Nature B.V
References Yurdagul, Sulzmaier, Chen, Pattillo, Schlaepfer, Orr (CR19) 2016; 129
Toshima, Hasegawa, Kurabayashi, Itabe, Takano, Sugano, Shimamura, Kimura, Michishita, Suzuki, Nagai (CR21) 2000; 20
Park, Febbraio, Silverstein (CR13) 2009; 119
Li, Mehta (CR16) 2005; 68
Janabi, Yamashita, Hirano, Sakai, Hiraoka, Matsumoto, Zhang, Nozaki, Matsuzawa (CR18) 2000; 20
Szilagyi, Gijbels, van der Velden, Heinsbroek, Kraal, de Winther, van den Berg (CR8) 2015; 239
Bisgaard, Mogensen, Rosendahl, Cucak, Nielsen, Rasmussen, Pedersen (CR26) 2016; 6
Fay, Panté (CR4) 2013; 444
Gilchrist, Thorsson, Li, Rust, Korb, Kennedy, Hai, Bolouri, Aderem (CR15) 2006; 441
Thiagarajan, Yakubenko, Elsori, Yadav, Willard, Tan, Rodriguez, Febbraio, Cathcart (CR7) 2013; 99
Nagatoshi, Kazuo (CR10) 2005; 4
Meisinger, Baumert, Khuseyinova, Loewel, Koenig (CR30) 2005; 112
Endemann, Stanton, Madden, Bryant, White, Protter (CR24) 1993; 268
Wang, Yu, Cao, Wang, Zheng, Tan, Zhao, Zhao, Wang, Harris (CR25) 2013; 14
Mor-Vaknin, Punturieri, Sitwala, Markovitz (CR6) 2003; 5
Eckes, Dogic, Colucci-Guyon, Wang, Maniotis, Ingber, Merckling, Langa, Aumailley, Delouvee (CR3) 1998; 111
CR29
Hatch (CR14) 1968; 6
Holvoet, Mertens, Verhamme, Bogaerts, Beyens, Verhaeghe, Collen, Muls, Werf (CR20) 2001; 21
Tousoulis, Oikonomou, Economou, Crea, Kaski (CR27) 2016; 37
Minin, Moldaver (CR1) 2009; 73
Mendez, Kojima, Goldman (CR5) 2010; 24
Jovinge, Ares, Kallin, Nilsson (CR17) 1996; 16
Ramji, Davies (CR28) 2015; 26
CR22
Gong, Dai, Chen, Wang, Yan, Shen, Liu, Yang, Hu, Yu, Liu, Zhang, Shen, Chen, Ding, Lu (CR9) 2019; 283
Libby (CR11) 2002; 420
Styers, Salazar, Love, Peden, Kowalczyk, Faundez (CR2) 2004; 15
Todd, Brown (CR12) 2008; 10
Haversen, Sundelin, Mardinoglu, Rutberg, Stahlman, Wilhelmsson, Hulten, Pekny, Fogelstrand, Bentzon (CR23) 2018; 8
D Li (1923_CR16) 2005; 68
MG Mendez (1923_CR5) 2010; 24
M Todd (1923_CR12) 2008; 10
C Wang (1923_CR25) 2013; 14
PS Thiagarajan (1923_CR7) 2013; 99
P Libby (1923_CR11) 2002; 420
M Janabi (1923_CR18) 2000; 20
L Haversen (1923_CR23) 2018; 8
LS Bisgaard (1923_CR26) 2016; 6
1923_CR22
YM Park (1923_CR13) 2009; 119
B Eckes (1923_CR3) 1998; 111
DP Ramji (1923_CR28) 2015; 26
K Szilagyi (1923_CR8) 2015; 239
1923_CR29
S Jovinge (1923_CR17) 1996; 16
G Endemann (1923_CR24) 1993; 268
P Holvoet (1923_CR20) 2001; 21
DH Gong (1923_CR9) 2019; 283
N Fay (1923_CR4) 2013; 444
A Yurdagul Jr (1923_CR19) 2016; 129
N Mor-Vaknin (1923_CR6) 2003; 5
FT Hatch (1923_CR14) 1968; 6
S Toshima (1923_CR21) 2000; 20
ML Styers (1923_CR2) 2004; 15
C Meisinger (1923_CR30) 2005; 112
AA Minin (1923_CR1) 2009; 73
M Gilchrist (1923_CR15) 2006; 441
F Nagatoshi (1923_CR10) 2005; 4
D Tousoulis (1923_CR27) 2016; 37
References_xml – volume: 10
  start-page: 497
  issue: 6
  year: 2008
  end-page: 504
  ident: CR12
  article-title: Biomarkers of atherosclerosis: clinical applications
  publication-title: Curr Cardiol Rep
  doi: 10.1007/s11886-008-0078-1
– volume: 68
  start-page: 353
  year: 2005
  end-page: 354
  ident: CR16
  article-title: Oxidized LDL, a critical factor in atherogenesis
  publication-title: Cardiovasc Res
  doi: 10.1016/j.cardiores.2005.09.009
– volume: 441
  start-page: 173
  year: 2006
  end-page: 178
  ident: CR15
  article-title: Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4
  publication-title: Nature
  doi: 10.1038/nature04768
– volume: 20
  start-page: 1953
  issue: 8
  year: 2000
  end-page: 1960
  ident: CR18
  article-title: Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.20.8.1953
– ident: CR22
– volume: 268
  start-page: 11811
  issue: 16
  year: 1993
  end-page: 11816
  ident: CR24
  article-title: CD36 is a receptor for oxidized low density lipoprotein
  publication-title: J Biol Chem
– volume: 5
  start-page: 59
  year: 2003
  end-page: 63
  ident: CR6
  article-title: Vimentin is secreted by activated macrophages
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb898
– volume: 24
  start-page: 1838
  year: 2010
  end-page: 1851
  ident: CR5
  article-title: Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition
  publication-title: FASEB J
  doi: 10.1096/fj.09-151639
– volume: 37
  start-page: 1723
  year: 2016
  end-page: 1732
  ident: CR27
  article-title: Inflammatory cytokines in atherosclerosis: current therapeutic approaches
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehv759
– volume: 4
  start-page: 281
  year: 2005
  end-page: 286
  ident: CR10
  article-title: Macrophages in inflammation
  publication-title: Curr Drug Targets Inflamm Allergy
  doi: 10.2174/1568010054022024
– volume: 111
  start-page: 1897
  year: 1998
  end-page: 1907
  ident: CR3
  article-title: Impaired mechanical stability, migration and contractile capacity in vimentin-deficient fibroblasts
  publication-title: J Cell Sci
– ident: CR29
– volume: 16
  start-page: 1573
  year: 1996
  end-page: 1579
  ident: CR17
  article-title: Human monocytes/macrophages release TNF-{alpha} in response to ox-LDL
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.16.12.1573
– volume: 444
  start-page: 181
  year: 2013
  end-page: 190
  ident: CR4
  article-title: The intermediate filament network protein, vimentin, is required for parvoviral infection
  publication-title: Virology
  doi: 10.1016/j.virol.2013.06.009
– volume: 73
  start-page: 1453
  year: 2009
  end-page: 1466
  ident: CR1
  article-title: Intermediate vimentin filaments and their role in intracellular organelle distribution
  publication-title: Biochem Mosc
  doi: 10.1134/S0006297908130063
– volume: 6
  start-page: 1
  year: 1968
  end-page: 68
  ident: CR14
  article-title: Practical methods for plasma lipoprotein analysis
  publication-title: Adv Lipid Res
  doi: 10.1016/B978-1-4831-9942-9.50008-5
– volume: 239
  start-page: 318
  year: 2015
  end-page: 321
  ident: CR8
  article-title: Dectin-1 deficiency does not affect atherosclerosis development in mice
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2015.02.005
– volume: 119
  start-page: 136
  year: 2009
  end-page: 145
  ident: CR13
  article-title: CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima
  publication-title: J Clin Invest
– volume: 20
  start-page: 2243
  issue: 10
  year: 2000
  end-page: 2247
  ident: CR21
  article-title: Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.20.10.2243
– volume: 8
  start-page: 16973
  year: 2018
  ident: CR23
  article-title: Vimentin deficiency in macrophages induces increased oxidative stress and vascular inflammation but attenuates atherosclerosis in mice
  publication-title: Sci Rep
  doi: 10.1038/s41598-018-34659-2
– volume: 26
  start-page: 673
  year: 2015
  end-page: 685
  ident: CR28
  article-title: Cytokines in atherosclerosis: key players in all stages of disease and promising therapeutic targets
  publication-title: Cytokine Growth Factor Rev
  doi: 10.1016/j.cytogfr.2015.04.003
– volume: 112
  start-page: 651
  year: 2005
  end-page: 657
  ident: CR30
  article-title: Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged Men from the general population
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.104.529297
– volume: 129
  start-page: 1580
  year: 2016
  end-page: 1591
  ident: CR19
  article-title: Oxidized LDL induces FAK-dependent RSK signaling to drive NF-kappaB activation and VCAM-1 expression
  publication-title: J Cell Sci
  doi: 10.1242/jcs.182097
– volume: 14
  start-page: 6
  year: 2013
  ident: CR25
  article-title: Characterization of murine macrophages from bone marrow, spleen and peritoneum
  publication-title: BMC Immunol
  doi: 10.1186/1471-2172-14-6
– volume: 6
  start-page: 35234
  year: 2016
  ident: CR26
  article-title: Bone marrow-derived and peritoneal macrophages have different inflammatory response to oxLDL and M1/M2 marker expression - implications for atherosclerosis research
  publication-title: Sci Rep
  doi: 10.1038/srep35234
– volume: 283
  start-page: 9
  year: 2019
  end-page: 16
  ident: CR9
  article-title: Secretory vimentin is associated with coronary artery disease in patients and induces atherogenesis in ApoE(-/-) mice
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2019.02.032
– volume: 15
  start-page: 5369
  year: 2004
  end-page: 5382
  ident: CR2
  article-title: The endo-lysosomal sorting machinery interacts with the intermediate filament cytoskeleton
  publication-title: Mol Biol Cell
  doi: 10.1091/mbc.e04-03-0272
– volume: 99
  start-page: 494
  year: 2013
  end-page: 504
  ident: CR7
  article-title: Vimentin is an endogenous ligand for the pattern recognition receptor Dectin-1
  publication-title: Cardiovasc Res
  doi: 10.1093/cvr/cvt117
– volume: 21
  start-page: 844
  year: 2001
  end-page: 848
  ident: CR20
  article-title: Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.21.5.844
– volume: 420
  start-page: 868
  year: 2002
  end-page: 874
  ident: CR11
  article-title: Inflammation in atherosclerosis
  publication-title: Nature
  doi: 10.1038/nature01323
– volume: 6
  start-page: 1
  year: 1968
  ident: 1923_CR14
  publication-title: Adv Lipid Res
  doi: 10.1016/B978-1-4831-9942-9.50008-5
– volume: 268
  start-page: 11811
  issue: 16
  year: 1993
  ident: 1923_CR24
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(19)50272-1
– volume: 6
  start-page: 35234
  year: 2016
  ident: 1923_CR26
  publication-title: Sci Rep
  doi: 10.1038/srep35234
– volume: 15
  start-page: 5369
  year: 2004
  ident: 1923_CR2
  publication-title: Mol Biol Cell
  doi: 10.1091/mbc.e04-03-0272
– volume: 111
  start-page: 1897
  year: 1998
  ident: 1923_CR3
  publication-title: J Cell Sci
  doi: 10.1242/jcs.111.13.1897
– volume: 283
  start-page: 9
  year: 2019
  ident: 1923_CR9
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2019.02.032
– volume: 37
  start-page: 1723
  year: 2016
  ident: 1923_CR27
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehv759
– volume: 4
  start-page: 281
  year: 2005
  ident: 1923_CR10
  publication-title: Curr Drug Targets Inflamm Allergy
  doi: 10.2174/1568010054022024
– volume: 24
  start-page: 1838
  year: 2010
  ident: 1923_CR5
  publication-title: FASEB J
  doi: 10.1096/fj.09-151639
– volume: 10
  start-page: 497
  issue: 6
  year: 2008
  ident: 1923_CR12
  publication-title: Curr Cardiol Rep
  doi: 10.1007/s11886-008-0078-1
– volume: 20
  start-page: 2243
  issue: 10
  year: 2000
  ident: 1923_CR21
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.20.10.2243
– volume: 8
  start-page: 16973
  year: 2018
  ident: 1923_CR23
  publication-title: Sci Rep
  doi: 10.1038/s41598-018-34659-2
– volume: 99
  start-page: 494
  year: 2013
  ident: 1923_CR7
  publication-title: Cardiovasc Res
  doi: 10.1093/cvr/cvt117
– volume: 5
  start-page: 59
  year: 2003
  ident: 1923_CR6
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb898
– volume: 16
  start-page: 1573
  year: 1996
  ident: 1923_CR17
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.16.12.1573
– ident: 1923_CR29
  doi: 10.2147/ijicmr.S64894
– volume: 441
  start-page: 173
  year: 2006
  ident: 1923_CR15
  publication-title: Nature
  doi: 10.1038/nature04768
– volume: 21
  start-page: 844
  year: 2001
  ident: 1923_CR20
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.21.5.844
– ident: 1923_CR22
  doi: 10.12688/f1000research.15967.1
– volume: 68
  start-page: 353
  year: 2005
  ident: 1923_CR16
  publication-title: Cardiovasc Res
  doi: 10.1016/j.cardiores.2005.09.009
– volume: 20
  start-page: 1953
  issue: 8
  year: 2000
  ident: 1923_CR18
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.20.8.1953
– volume: 14
  start-page: 6
  year: 2013
  ident: 1923_CR25
  publication-title: BMC Immunol
  doi: 10.1186/1471-2172-14-6
– volume: 129
  start-page: 1580
  year: 2016
  ident: 1923_CR19
  publication-title: J Cell Sci
  doi: 10.1242/jcs.182097
– volume: 119
  start-page: 136
  year: 2009
  ident: 1923_CR13
  publication-title: J Clin Invest
– volume: 112
  start-page: 651
  year: 2005
  ident: 1923_CR30
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.104.529297
– volume: 26
  start-page: 673
  year: 2015
  ident: 1923_CR28
  publication-title: Cytokine Growth Factor Rev
  doi: 10.1016/j.cytogfr.2015.04.003
– volume: 444
  start-page: 181
  year: 2013
  ident: 1923_CR4
  publication-title: Virology
  doi: 10.1016/j.virol.2013.06.009
– volume: 239
  start-page: 318
  year: 2015
  ident: 1923_CR8
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2015.02.005
– volume: 420
  start-page: 868
  year: 2002
  ident: 1923_CR11
  publication-title: Nature
  doi: 10.1038/nature01323
– volume: 73
  start-page: 1453
  year: 2009
  ident: 1923_CR1
  publication-title: Biochem Mosc
  doi: 10.1134/S0006297908130063
SSID ssj0017594
Score 2.4793994
Snippet Activated macrophages show increased expression of vimentin, an intermediate filament protein. Macrophages secrete vimentin into extracellular space; however,...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 973
SubjectTerms Apolipoprotein E
Arteriosclerosis
Atherosclerosis
Biomedical and Life Sciences
Biomedicine
Cardiovascular disease
CD36 antigen
Coronary artery
Coronary vessels
Cytokines
Cytoskeleton
Diet
Focal adhesion kinase
Heart diseases
Human Genetics
Inflammation
Interleukin 6
Internal Medicine
Lipoproteins
Low density lipoprotein
Macrophages
Molecular Medicine
NF-κB protein
Original Article
Phosphorylation
Tumor necrosis factor-α
Vimentin
SummonAdditionalLinks – databaseName: SpringerLink Journals (ICM)
  dbid: U2A
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bS8MwFA46QXwR706nRPBNA72kSfs41DFk0xcHeytJmuJAW1k7p_56T7K2IlPBx9I0KeckOd_hOxeEzpVOhCtpQCjlPjgojiLS1YKYUlRhaEyq7UM2vGP9Eb0dB-MqKayoo91rStLe1E2ym2VxiHF3LCwh81W0FoDvbgK5Rl634Q54YNsfgt_CiAfuQJUq8_Mc383REsZc4ket2eltoc0KL-LuQsHbaEVnO2h9WDHiuyi9f5skkw-d4MH1AIODDaoq8Kut2T_JcGFQoZE9lu_4WZh-XY9wgxRYZAm2Yeqm3xU8lzm2WDAvYJlpDqvBZClsl0Vq4x4a9W4ervqk6p1AFHWjknBPKqVDbojYSDs8MbaYs9TUAeWu4lQDjlGu8FPOAlMkUkovUQDXvMTRUSj9fdTK8kwfIiw406kSQkRKUBqpiIYi9cH2hZFMWOq3kVuLMFZVYXHT3-IpbkoiW7HHIPbYij2et9FF883LoqzGn6M7tWbi6ogVseWyKfUc1kZnzWs4HIbxEJnOZ2aMwyJwtUP4yYOFRpvlAEkGLuNuG13WKv6a_Pd_Ofrf8GO04dntZgJ8O6hVTmf6BGBMKU_trv0E3rXn3A
  priority: 102
  providerName: Springer Nature
Title Oxidized LDL induces vimentin secretion by macrophages and contributes to atherosclerotic inflammation
URI https://link.springer.com/article/10.1007/s00109-020-01923-w
https://www.ncbi.nlm.nih.gov/pubmed/32451671
https://www.proquest.com/docview/2421244206
https://www.proquest.com/docview/2406952383
Volume 98
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dTxQxEJ8gJMYXg_h1iqQmvmnjfvTa3Sdz6AFBQGO85Hza9GvjJbqL7AHCX89Mr7eEEHja7G5323Smnd902vkBvLPe6dSIIRdC5eigJJab1GtOqaiKgkxq4CE7PJJ7E7E_HU7jglsXt1Uu58QwUbvW0hr5xxC6FCJL5Kfjf5xYoyi6Gik0HsAapS4jrVbT3uFCyxiIENGDkTxDxyAemglH50JMiJPzFEAOP79pmG6hzVuR0mCAdtbhcUSObLQQ9RNY8c0GPDyMsfGnUH_7P3OzS-_YwZcDhq42Cq1jZyF7_6xhHeFDkgIzF-yvJuau3ziXdEw3joUN68R8hffzlgVU2HZYzUmLteHPalScxSHHZzDZGf_8vMcjiwK3Ii3nXGXGWl8oCsmWPlGOrLKSNWUEValVwiOisanOayWHlC7SmMxZBG6ZS3xZmPw5rDZt418C00r62mqtS6uFKG0pCl3naAWL0jhZ5wNIl11Y2ZhinJgu_lR9cuTQ7RV2exW6vTofwPv-m-NFgo17S28uJVPFwdZV16oxgLf9axwmFPvQjW9PqUwiS3S6C2zki4VE--oQUw5TqdIBfFiK-Prnd7fl1f1teQ2PsqBetLV3E1bnJ6f-DQKYudkKWroFa6PdX1_HeN0eH33_gU8n2egKG6LuhA
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgEXxJuFAkaCE1jk4bWTA0KIUm3pbrm00t6CX1FXKklptizlR_U3dsZ5VKiitx6jOLY1M_bMl7HnA3hjvdOxEWMuhEoRoESWm9hrTqWosoxcauAhm-3Kyb74Nh_P1-CsvwtDxyr7PTFs1K629I_8Q0hdCpFE8tPRL06sUZRd7Sk0WrPY8acrhGzNx-1N1O_bJNn6uvdlwjtWAW5FnC-5Soy1PlOUosx9pBx5KSVLqpCpYquERw9vY52WSo6pfKIxibMYyCQu8nlmUuz3BtxExxsR2FPzAeChJw7Ei4iYJE8QiHSXdMJVvZCD4gTWQlDFV_86wkvR7aXMbHB4W_fgbhepss-tad2HNV89gFuzLhf_EMrvfxZu8dc7Nt2cMoT2aCQN-x3YAhYVaygeJa0zc8p-amIKO8C9q2G6ciwckCemLXxe1ixEoXWDwxzXOBp2VqKhtpcqH8H-tcj3MaxXdeWfAtNK-tJqrXOrhchtLjJdpuh1s9w4WaYjiHsRFrYraU7MGofFUIw5iL1AsRdB7MVqBO-Gb47agh5Xtt7oNVN0i7spLkxxBK-H17gsKdeiK1-fUJtI5gjyM5zkk1ajw3AYw45jqeIRvO9VfNH5_-fy7Oq5vILbk73ZtJhu7-48hztJMDU6VrwB68vjE_8Cg6eleRkslsGP614i5yKeJUU
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrVRxQbxZKGAkOIHVPBw7OSAEbFct3S4VolJvwXYcsRIkpdmylJ_Gr2PGeVSoorceozi2NQ_PTMYzH8Bz6wodGpFwIVSMAUpguQmd5tSKKk3JpHocsv253DkUH46SozX409fC0LXK_kz0B3VRW_pHvuVTl0JEgdwqu2sRB5Ppm-MfnBCkKNPaw2m0IrLnzlYYvjWvdyfI6xdRNN3-_H6HdwgD3IowW3IVGWtdqihdmblAFWSxlCypW6YKrRIOrb0NdVwqmVArRWOiwqJTExWBy1IT47zXYF1RVDSC9Xfb84NPQw5DJR6GEeMnySMMS7qSHV-45zNSnEI372Lx1b9m8YKveyFP683f9Cbc6PxW9rYVtFuw5qrbsLHfZebvQPnx16JY_HYFm01mDAN9FJmG_fTYAYuKNeSdkgwwc8a-a8IN-4onWcN0VTB_XZ5wt_B5WTPvk9YNLnNS42o4WYli25ZY3oXDK6HwPRhVdeUeANNKutJqrTOrhchsJlJdxmiD08wUsozHEPYkzG3X4JxwNr7lQ2tmT_YcyZ57suerMbwcvjlu23tcOnqz50zeqXqTnwvmGJ4Nr1FJKfOiK1ef0phAZhjyp7jJ-y1Hh-XQo01CqcIxvOpZfD75__fy8PK9PIUNVI98tjvfewTXIy9pdMd4E0bLk1P3GD2ppXnSiSyDL1etJX8BFu0q4A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Oxidized+LDL+induces+vimentin+secretion+by+macrophages+and+contributes+to+atherosclerotic+inflammation&rft.jtitle=Journal+of+molecular+medicine+%28Berlin%2C+Germany%29&rft.au=Kim%2C+SeoYeon&rft.au=Cho%2C+Wonkyoung&rft.au=Kim%2C+Inyeong&rft.au=Lee%2C+Sang-Hak&rft.date=2020-07-01&rft.eissn=1432-1440&rft_id=info:doi/10.1007%2Fs00109-020-01923-w&rft_id=info%3Apmid%2F32451671&rft.externalDocID=32451671
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0946-2716&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0946-2716&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0946-2716&client=summon